10 March 2009
Landmark Paper Compares Scientific Productivity and Impact of the Top 100 Alzheimer's Disease Investigators
Amsterdam, The Netherlands – IOS Press is pleased to announce the publication of a landmark study in which both traditional and highly-innovative scientometric approaches are employed to measure scientific productivity and impact of the top 100 Alz
10 March 2009
A Simple Balance Test May Predict Cognitive Decline in Alzheimer's Disease
Amsterdam, The Netherlands – A simple balance test may predict cognitive decline in Alzheimer’s Disease, according to a study published in the March 2009 issue of the Journal of Alzheimer’s Disease.
10 March 2009
Anesthesia is found to induce hyperphosphorylation of tau at sites related to Alzheimer's disease
Staten Island, NY—Scientists from The New York State Office of Mental Retardation and Develop-mental Disabilities’ (OMRDD) New York State Institute for Basic Research in Developmental Disabilities (IBR) report today in the March issue of the Journal of Alzheime
16 February 2009
Mechanisms that prevent Alzheimer's Disease: Enzymatic activity plays key role
Journal of Alzheimer's Disease (JAD) publishes new findings on the protective effects of the enzyme α-secretase
16 February 2009
New Study Provides Insight Into Ways Organ Systems Outside the Brain May Affect Alzheimer's Disease
Seattle, Wash. – In Alzheimer’s disease the brain accumulates a molecule called A-beta (Aβ) that can be quite toxic to brain cells. Many researchers believe that finding ways to clear Aβ may be a key to treatment or prevention of Alzheimer’s disease.
22 January 2009
New Study Provides Further Evidence That Apple Juice Can Delay Onset of Alzheimer’s Disease
Amsterdam, The Netherlands – A growing body of evidence demonstrates that we can take steps to delay age-related cognitive decline, including in some cases that which accompanies Alzheimer’s disease, according to a study published in the January 20
15 January 2009
Possible Alzheimer's Disease Marker Discovered in Rare Genotype
Amsterdam, The Netherlands and Sun City, AZ, USA – Researchers at Banner Health’s Sun Health Research Institute have uncovered evidence that Alzheimer’s disease (AD) may be clinically confirmed in patients with apolipoprotein E2 homozygote.
14 January 2009
Midlife coffee and tea drinking and the risk of late-life dementia
Stockholm, Sweden -- Midlife coffee drinking can decrease the risk of dementia/Alzheimer's disease (AD) later in life.
15 December 2008
Alzheimer’s Research Using Animal Models Significantly Increases Understanding of the Disease
Amsterdam, The Netherlands–Very few species spontaneously develop the cognitive, behavioral and neuropathological symptoms of Alzheimer’s disease (AD), yet AD research must progress at a more rapid pace than the rate of human aging.
Pages
